---
title: "Infectious Disease Guidelines"
tags: [guidelines, infectious-disease, antibiotics]
sidebar: ccms_guidelines_sidebar
permalink: /guidelines/infectious-disease-guidelines.html
summary: Evidence-based guidelines for infectious disease management
---

# Infectious Disease Guidelines

Comprehensive guidelines for the prevention, diagnosis, and treatment of infectious diseases.

## Antimicrobial Stewardship

### Principles
- **Appropriate Selection**: Right drug, right dose, right duration
- **Empiric Therapy**: Based on local resistance patterns
- **De-escalation**: Narrow spectrum when culture results available
- **Duration**: Shortest effective course

### Common Infections

#### Community-Acquired Pneumonia
- **Mild**: Amoxicillin 1g TID or doxycycline 100mg BID
- **Moderate**: Amoxicillin-clavulanate + azithromycin
- **Severe**: Ceftriaxone + azithromycin or levofloxacin

#### Urinary Tract Infections
- **Uncomplicated Cystitis**: Nitrofurantoin 100mg BID × 5 days
- **Pyelonephritis**: Ciprofloxacin 500mg BID × 7 days
- **Complicated UTI**: Piperacillin-tazobactam or meropenem

#### Skin and Soft Tissue Infections
- **Cellulitis**: Cephalexin 500mg QID × 7-10 days
- **MRSA Suspected**: Clindamycin or doxycycline
- **Severe**: Vancomycin + piperacillin-tazobactam

## Hospital-Acquired Infections

### Prevention Strategies
- **Hand Hygiene**: Alcohol-based hand rub or soap and water
- **Central Line Bundle**: Maximum barrier precautions
- **VAP Prevention**: Elevate head of bed, daily sedation vacation
- **CAUTI Prevention**: Catheter removal when no longer needed

### Management
- **Central Line-Associated Bloodstream Infection**: Remove catheter, blood cultures
- **Ventilator-Associated Pneumonia**: Bronchoscopy, quantitative cultures
- **Catheter-Associated UTI**: Remove catheter, urine culture

## Antibiotic Resistance

### High-Priority Pathogens
- **Carbapenem-Resistant Enterobacteriaceae (CRE)**
- **Methicillin-Resistant Staphylococcus aureus (MRSA)**
- **Vancomycin-Resistant Enterococcus (VRE)**
- **Multidrug-Resistant Pseudomonas aeruginosa**

### Management Strategies
- **Contact Precautions**: For resistant organisms
- **Antimicrobial Cycling**: Rotate antibiotic classes
- **Restriction Policies**: Limit use of broad-spectrum agents
- **Surveillance**: Monitor resistance patterns

## Travel Medicine

### Pre-Travel Assessment
- **Destination-Specific Risks**: Malaria, yellow fever, typhoid
- **Vaccination Status**: Routine and travel vaccines
- **Medical Conditions**: Immunocompromised, pregnancy
- **Travel Duration**: Short-term vs. long-term

### Common Travel Illnesses
- **Traveler's Diarrhea**: Loperamide + azithromycin
- **Malaria Prophylaxis**: Atovaquone-proguanil, doxycycline
- **Altitude Sickness**: Acetazolamide prophylaxis
- **Motion Sickness**: Meclizine, scopolamine

## References
- Infectious Diseases Society of America Guidelines
- Centers for Disease Control and Prevention Guidelines
- World Health Organization Recommendations
